Cargando…

M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION

Detalles Bibliográficos
Autores principales:	Patterson, A., Ren, Z., Jerath, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566852/ http://dx.doi.org/10.1016/j.anai.2021.08.189

Ejemplares similares

VITT REACTION ASSOCIATED WITH JOHNSON & JOHNSON COVID-19 VACCINE
por: AKUNA, MELANIE, et al.
Publicado: (2021)

A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
por: Patel, Rikin, et al.
Publicado: (2022)

Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine
por: Sowell, Josiah, et al.
Publicado: (2021)

Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021)

Johnson and Johnson COVID-19 Vaccination Triggering Pheochromocytoma Multisystem Crisis
por: Haji, Nahel, et al.
Publicado: (2021)

ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine
por: Yadav, Rukesh, et al.
Publicado: (2022)

COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration
por: Wagner, Abram L., et al.
Publicado: (2023)

Reply to “Widespread Cutaneous Reaction to the Johnson & Johnson Ad26.Cov2.S Vaccine”
por: Malachowski, Stephen J., et al.
Publicado: (2022)

Transverse myelitis after Johnson & Johnson COVID-19 vaccine: illustrative case
por: Mathew, Ezek, et al.
Publicado: (2022)

Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report
por: Elboraey, Mohamed Omar, et al.
Publicado: (2021)

Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination
por: Carranza, Octavio, et al.
Publicado: (2022)

Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine
por: Malik, Bilal, et al.
Publicado: (2021)

Evaluating Johnson and Johnson COVID-19 Vaccination Outcomes in a Low-Income Hispanic Population
por: Lamb, Christopher, et al.
Publicado: (2023)

Patients with Pseudoallergic Reactions Following COVID-19 Vaccination are Able to Tolerate Subsequent Dosing
por: Patterson, Alexander, et al.
Publicado: (2022)

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
por: Shay, David K., et al.
Publicado: (2021)

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
por: Self, Wesley H., et al.
Publicado: (2021)

Stevens‐Johnson Syndrome due to COVID‐19 vaccination
por: Mansouri, Parvin, et al.
Publicado: (2021)

Brève : Covid-19 : le vaccin Johnson & Johnson approuvé à l’unanimité par la FDA
por: Dalmat, Yann-Mickael
Publicado: (2021)

THE CLOT THICKENS: DOES THE JOHNSON & JOHNSON COVID-19 VACCINE INCREASE THE RISK OF THROMBUS IN A HYPERCOAGULABLE STATE?
por: RUTENBERG, DAVID, et al.
Publicado: (2021)

Acute Multiple Sclerosis Exacerbation After Vaccination With the Johnson & Johnson COVID-19 Vaccine: Novel Presentation and First Documented Case Report
por: Al-Midfai, Younus, et al.
Publicado: (2022)

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
por: Rosenblum, Hannah G., et al.
Publicado: (2021)

Sinopharm COVID-19 vaccine-induced Stevens–Johnson syndrome
por: Boualila, L., et al.
Publicado: (2022)

Stevens-Johnson Syndrome Due to Influenza Vaccination
por: Tong, Jonathan, et al.
Publicado: (2020)

Dr. John M. Johnson
por: Johnson, Jno. M.
Publicado: (1875)

Dr. Thomas M. Johnson
Publicado: (1916)

Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2
por: Bangolo, Ayrton, et al.
Publicado: (2022)

Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals
por: Nittner-Marszalska, Marita, et al.
Publicado: (2021)

A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)()
por: Castan, Maxime, et al.
Publicado: (2022)

Life of Johnson /
por: Boswell, James, 1740-1795
Publicado: (1980)

Philip Johnson
por: Jacobus, John M.
Publicado: (1962)

Mister Johnson /
por: Cary, Joyce, 1888-1957
Publicado: (1953)

Samuel Johnson /
por: Wain, John

Johnson’s Cyclopedia
Publicado: (1889)

337 Relapse of Membranous Nephropathy and Renal Sarcoidosis Following Exposure to SARS-CoV-2 Vaccine (Johnson & Johnson)
Publicado: (2022)

Death of Dr. John M. Johnson
Publicado: (1886)

Tribute to Dr. J. M. Johnson
Publicado: (1886)

Severe nonanaphylactic allergic reaction to the Pfizer-BioNTech COVID-19 vaccine
por: Doughty, Hayden, et al.
Publicado: (2021)

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
por: Oliver, Sara E., et al.
Publicado: (2022)

A Case Report of Acute Severe Necrotizing Pancreatitis following the Johnson & Johnson Vaccine against the Novel SARS-CoV-2
por: Bangolo, Ayrton I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_56819443rsdd3hmc12l1849rlj